West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Real-Time Price · USD

358.24

-4.20 (-1.16%)

At close: Jul 17, 2026, 4:00 PM EDT

365.40

+7.16 (2.00%)

After-hours: Jul 17, 2026, 7:11 PM EDT

WST Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,221	3,074	2,893	2,950	2,887	2,832
Revenue Growth (YoY)	11.23%	6.25%	-1.92%	2.18%	1.95%	31.89%
Cost of Revenue	2,053	1,970	1,895	1,821	1,751	1,656
Gross Profit	1,169	1,104	998.5	1,129	1,136	1,176
Selling, General & Admin	405.1	393.6	338.5	353.4	316.9	362.8
Research & Development	73.8	74.3	69.1	68.4	58.5	52.8
Other Operating Expenses	34.6	51.2	21	31.4	26.8	7.9
Total Operating Expenses	513.5	519.1	428.6	453.2	402.2	423.5
Operating Income	655	584.9	569.9	676	734	752.3
Interest Income	23.8	17.5	19.6	28	5.1	1
Interest Expense	-2.2	-0.5	-3	-9	-7.9	-8.2
Other Non-Operating Income (Expense)	-1	-1	-1	3	-51.3	3.8
Total Non-Operating Income (Expense)	20.6	16	15.6	22	-54.1	-3.4
Pretax Income	675.6	600.9	585.5	698	679.9	748.9
Provision for Income Taxes	142.2	121.6	107.5	122.3	114.7	107.2
Net Income	542.7	493.7	492.7	593.4	585.9	661.8
Minority Interest in Earnings	-14.4	-14.4	-14.7	-17.7	-20.7	-20.1
Net Income to Common	557.1	508.1	507.4	611.1	606.6	681.9
Net Income Growth	15.82%	0.14%	-16.97%	0.74%	-11.04%	87.54%
Shares Outstanding (Basic)	72	72	73	74	74	74
Shares Outstanding (Diluted)	73	73	74	75	76	76
Shares Change (YoY)	-1.09%	-1.36%	-2.13%	-0.66%	-0.66%	0.66%
EPS (Basic)	7.52	6.83	6.75	7.98	7.87	8.89
EPS (Diluted)	7.48	6.79	6.69	7.88	7.73	8.67
EPS Growth	17.42%	1.49%	-15.10%	1.94%	-10.84%	89.72%
Free Cash Flow	458	468.9	276.4	414.5	439.4	330.6
Free Cash Flow Growth	-2.33%	69.64%	-33.32%	-5.67%	32.91%	10.90%
Free Cash Flow Per Share	6.31	6.45	3.75	5.50	5.80	4.33
Dividends Per Share	0.860	0.850	0.810	0.770	0.730	0.690
Dividend Growth	1.18%	4.94%	5.20%	5.48%	5.80%	6.15%
Gross Margin	36.28%	35.91%	34.51%	38.28%	39.36%	41.52%
Operating Margin	20.34%	19.03%	19.70%	22.92%	25.43%	26.57%
Profit Margin	16.85%	16.06%	17.03%	20.12%	20.30%	23.37%
FCF Margin	14.22%	15.25%	9.55%	14.05%	15.22%	11.68%
EBITDA	831.6	756.3	725.3	813.3	854.6	874.6
EBITDA Margin	25.82%	24.60%	25.07%	27.57%	29.60%	30.89%
EBIT	655	584.9	569.9	676	734	752.3
EBIT Margin	20.34%	19.03%	19.70%	22.92%	25.43%	26.57%
Effective Tax Rate	21.05%	20.24%	18.36%	17.52%	16.87%	14.31%

SEC Filings: 10-K · 10-Q